Segui
Anna Cichonska
Anna Cichonska
Institute for Molecular Medicine Finland FIMM, University of Helsinki
Email verificata su helsinki.fi
Titolo
Citata da
Citata da
Anno
Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank
H Julkunen, A Cichońska, M Tiainen, H Koskela, K Nybo, V Mäkelä, ...
Nature communications 14 (1), 604, 2023
2082023
Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population
H Julkunen, A Cichońska, PE Slagboom, P Würtz, ...
elife 10, e63033, 2021
1532021
metaCCA: summary statistics-based multivariate meta-analysis of genome-wide association studies using canonical correlation analysis
A Cichonska, J Rousu, P Marttinen, AJ Kangas, P Soininen, T Lehtimäki, ...
Bioinformatics 32 (13), 1981-1989, 2016
1462016
Computational-experimental approach to drug-target interaction mapping: a case study on kinase inhibitors
A Cichonska, B Ravikumar, E Parri, S Timonen, T Pahikkala, A Airola, ...
PLoS computational biology 13 (8), e1005678, 2017
1252017
Leveraging multi-way interactions for systematic prediction of pre-clinical drug combination effects
H Julkunen, A Cichonska, P Gautam, S Szedmak, J Douat, T Pahikkala, ...
Nature communications 11 (1), 6136, 2020
1012020
Learning with multiple pairwise kernels for drug bioactivity prediction
A Cichonska, T Pahikkala, S Szedmak, H Julkunen, A Airola, M Heinonen, ...
Bioinformatics 34 (13), i509-i518, 2018
842018
Crowdsourced mapping of unexplored target space of kinase inhibitors
A Cichońska, B Ravikumar, RJ Allaway, F Wan, S Park, O Isayev, S Li, ...
Nature communications 12 (1), 3307, 2021
762021
Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy
I Honeyborne, TD McHugh, I Kuittinen, A Cichonska, D Evangelopoulos, ...
BMC medicine 14, 1-13, 2016
682016
Identification of drug candidates and repurposing opportunities through compound–target interaction networks
A Cichonska, J Rousu, T Aittokallio
Expert opinion on drug discovery 10 (12), 1333-1345, 2015
622015
Integrative analysis of metabolite GWAS illuminates the molecular basis of pleiotropy and genetic correlation
CJ Smith, N Sinnott-Armstrong, A Cichońska, H Julkunen, EB Fauman, ...
Elife 11, e79348, 2022
392022
Effects of general and central adiposity on circulating lipoprotein, lipid, and metabolite levels in UK Biobank: a multivariable Mendelian randomization study
JA Bell, TG Richardson, Q Wang, E Sanderson, T Palmer, V Walker, ...
The Lancet Regional Health–Europe 21, 2022
342022
Nightingale Health UK Biobank Initiative Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population
H Julkunen, A Cichońska, PE Slagboom, P Würtz
Elife 10, e63033, 2021
262021
An expanded analysis framework for multivariate GWAS connects inflammatory biomarkers to functional variants and disease
SE Ruotsalainen, JJ Partanen, A Cichonska, J Lin, C Benner, I Surakka, ...
European Journal of Human Genetics 29 (2), 309-324, 2021
232021
Modeling drug combination effects via latent tensor reconstruction
T Wang, S Szedmak, H Wang, T Aittokallio, T Pahikkala, A Cichonska, ...
Bioinformatics 37 (Supplement_1), i93-i101, 2021
222021
Circulating metabolic biomarkers are consistently associated with type 2 diabetes risk in Asian and European populations
JYH Seah, Y Hong, A Cichońska, C Sabanayagam, S Nusinovici, ...
The Journal of Clinical Endocrinology & Metabolism 107 (7), e2751-e2761, 2022
212022
AI for targeted polypharmacology: The next frontier in drug discovery
A Cichońska, B Ravikumar, R Rahman
Current Opinion in Structural Biology 84, 102771, 2024
202024
Investigating the conformational landscape of AlphaFold2-predicted protein kinase structures
C Al-Masri, F Trozzi, SH Lin, O Tran, N Sahni, M Patek, A Cichonska, ...
Bioinformatics Advances 3 (1), vbad129, 2023
142023
Blood biomarker score identifies individuals at high risk for severe COVID-19 a decade prior to diagnosis: metabolic profiling of 105,000 adults in the UK Biobank
Nightingale Health UK Biobank Initiative, H Julkunen, A Cichońska, ...
MedRxiv, 2020.07. 02.20143685, 2020
112020
Atlas of plasma nuclear magnetic resonance biomarkers for health and disease in 118,461 individuals from the UK Biobank
H Julkunen, A Cichońska, M Tiainen, H Koskela, K Nybo, V Mäkelä, ...
medRxiv, 2022.06. 13.22276332, 2022
102022
A solution for large scale nonlinear regression with high rank and degree at constant memory complexity via latent tensor reconstruction
S Szedmak, A Cichonska, H Julkunen, T Pahikkala, J Rousu
arXiv preprint arXiv:2005.01538, 2020
82020
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20